Sign up to read this article for FREE!
After signing up, you'll start to receive regular news updates from us.
Sysmex to Distribute Affymetrix’s Diagnostic Arrays
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Affymetrix
has hired Japanese lab diagnostics company
Sysmex
to sell its GeneChip diagnostic arrays and instruments in Japan, and has enabled the company to develop and market its own in vitro diagnostics based on the GeneChip platform.
The deal gives Sysmex exclusive rights to distribute the diagnostic arrays and instruments in Japan, and could enable it to distribute the products to other countries in Southeast Asia.
The company currently has tests in the areas of urinalysis, immunochemistry, hematology, and hemostasis, and is now marketing a test to detect lymph node metastases in breast cancer patients.
Financial terms of the agreements were not released.
The deal gives Sysmex exclusive rights to distribute the diagnostic arrays and instruments in Japan, and could enable it to distribute the products to other countries in Southeast Asia.
Another part of the agreement gives Sysmex non-exclusive rights to use the GeneChip to develop and market its in vitro tests worldwide.
The company currently has tests in the areas of urinalysis, immunochemistry, hematology, and hemostasis, and is now marketing a test to detect lymph node metastases in breast cancer patients.
Financial terms of the agreements were not released.
